http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30949468

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 96
issn 0268-1315
issueIdentifier 2
pageRange 87-96
publicationName International Clinical Psychopharmacology
startingPage 87
bibliographicCitation Kasper S, Herman B, Nivoli G, Van Ameringen M, Petralia A, Mandel FS, Baldinetti F, Bandelow B. Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial. Int Clin Psychopharmacol. 2009 Mar;24(2):87–96. doi: 10.1097/yic.0b013e32831d7980. PMID: 21456104.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81cc3c948382a0ae212a62007b9b1fbc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65e1cefbfed43f459db9a9967e2b5bb5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7afbd8adacaf43cec82e5cfab41a299f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f31aa1f16ce04a23b34ebf745c0764ce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6860837c7dee9c29d774bcb29e74e5f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2511-3768
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba39bcfe3ebb232f4fa63e7a397edb38
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_663a24a964734a4c1582893fa6921e26
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8278-191X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e04101c054f94018a6780e7e8a96b6b2
date 200903
identifier https://doi.org/10.1097/yic.0b013e32831d7980
https://pubmed.ncbi.nlm.nih.gov/21456104
isPartOf https://portal.issn.org/resource/ISSN/0268-1315
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4793
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial
discusses http://id.nlm.nih.gov/mesh/M0026372
http://id.nlm.nih.gov/mesh/M0214473
http://id.nlm.nih.gov/mesh/M0008927
http://id.nlm.nih.gov/mesh/M0014964
http://id.nlm.nih.gov/mesh/M0021830
http://id.nlm.nih.gov/mesh/M0005471
http://id.nlm.nih.gov/mesh/M0136959
http://id.nlm.nih.gov/mesh/M0028006
http://id.nlm.nih.gov/mesh/M0021771
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D003511Q000627
http://id.nlm.nih.gov/mesh/D001008Q000188
http://id.nlm.nih.gov/mesh/D014151Q000627
http://id.nlm.nih.gov/mesh/D018691Q000627
http://id.nlm.nih.gov/mesh/D014179Q000627
http://id.nlm.nih.gov/mesh/D005680Q000031
hasSubjectTerm http://id.nlm.nih.gov/mesh/D001008Q000503
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D005680Q000009
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D010352
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D003511Q000009
http://id.nlm.nih.gov/mesh/D000069583
http://id.nlm.nih.gov/mesh/D005680Q000627
http://id.nlm.nih.gov/mesh/D009638Q000502
http://id.nlm.nih.gov/mesh/D017367Q000009
http://id.nlm.nih.gov/mesh/D011569
http://id.nlm.nih.gov/mesh/D000069470
http://id.nlm.nih.gov/mesh/D014151Q000009
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D018691Q000009
http://id.nlm.nih.gov/mesh/D014179Q000009
http://id.nlm.nih.gov/mesh/D011788
http://id.nlm.nih.gov/mesh/D013997
http://id.nlm.nih.gov/mesh/D017367Q000627
http://id.nlm.nih.gov/mesh/D039721
http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5486971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5656
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6923

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129228530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127479071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127564392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129095671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128942828

Total number of triples: 74.